Monday, March 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Self-Swabs vs. Caregiver Swabs for COVID Tests: New Study Shows Similar Accuracy

by Global Biodefense Staff
January 30, 2021
Self-Swabs vs. Caregiver Swabs for COVID Tests: New Study Shows Similar Accuracy

Photo by Mufid Majnun / Unsplash

Self swabs and caregiver swabs are effective at detecting multiple pathogens and are just as accurate as those taken by healthcare workers, according to a team of Australian researchers. The research appears in the Journal of Clinical Microbiology, a publication of the American Society for Microbiology.

“Across the range of pathogens and swab types, there was high agreement between results from self- or caregiver swabs and those performed by a healthcare worker, even when different sites were swabbed (e.g. nasopharyngeal vs. nasal),” said principal investigator Joshua Osowicki, BMedSci, MBBS, FRACP, a Pediatric Infectious Diseases physician in the Murdoch Children’s Research Institute’s Tropical Diseases research group, Melbourne, Australia.

“We found a pooled sensitivity of 91% and specificity of 98% for self- or caregiver-collected upper airway swabs compared to [healthcare worker] swabs,” the investigators wrote. (Sensitivity refers to the proportion of those who test positive that are correctly identified, and specificity the proportion testing negative that are correctly identified.)

“Findings were similar when only SARS-CoV-2 data were considered,” the researchers wrote. “This level of diagnostic performance should reassure clinicians, researchers, and public health officials that diagnostic performance is not necessarily compromised by self- or caregiver swabbing.”

Pathogens swabbed in the study include SARS-CoV-2, influenza, group A Streptococcus, Staphylococcus aureus, pharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae, and a panel of respiratory viruses.

The study was a systematic review and meta-analysis of 20 previous studies comprising swabs of more than 3,500 individuals, comparing self- or caregiver swabs with swabs collected by healthcare workers for diagnosis of a range of upper airway pathogens. “We searched for previous studies that included both kinds of swabs collected from the same individuals,” said Dr. Osowicki. “For each study, we considered the sensitivity and specificity of self- or caregiver swabs compared to swabs by healthcare workers, and the agreement between the two kinds of swabs.

Self- and caregiver swabbing offer a number of advantages over swabbing by healthcare workers, including less likelihood of transmission, reduced expenses, conservation of personal protective equipment, and less discomfort to patients. An online survey of patients with SARS-CoV-2 symptoms found a much higher proportion willing to be tested via a self-collected saliva sample (92%) or a nasal swab (88%) than by a drive-through healthcare worker swab collection (71%),” according to the investigators.

When the plans of then medical student and first author Ciara Harrison to complete an immunology laboratory project were derailed by the pandemic, Dr. Harrison, now a first-year physician, pivoted to this systematic review and meta-analysis.

A systematic review and meta-analysis of upper airways swab collection for detection of viral and bacterial pathogens by individuals or caregivers compared to healthcare workers. Journal of Microbiology, 19 January 2021.

Tags: COVID-19Editor PickPublic Health EmergencyRapid DiagnosticsSARS-CoV-2

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
The device appears smaller than a playing card, transparent, with visible channels branching off.
Medical Countermeasures

How Organ-on-a-chip Models Could Grease the Drug Development Pipeline

January 10, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC